«The induced pluripotent stem cells we used in this study proved to be extremely useful in disease modelling, and they could offer an
excellent platform for drug discovery and testing new
therapeutic targets for Alzheimer's disease in the future,» says Early Stage Researcher Minna Oksanen, the lead author of the study.